Citation Impact
Citing Papers
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
2008 Standout
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
2004 Standout
Five-Year Outcomes of a Randomized Phase III Trial Comparing Adjuvant Chemotherapy With S-1 Versus Surgery Alone in Stage II or III Gastric Cancer
2011 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
2003 Standout
Small Cell Carcinocythemia
1999
The changing epidemiology of lung cancer in Europe
2003
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Inflammation and Alzheimer's disease
2000 Standout
Conventional external irradiation alone as adjuvant treatment in resectable pancreatic cancer: results of a prospective study
1992
Pancreatic cancer
2004 Standout
Testicular Germ-Cell Cancer
1997 Standout
Single‐institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting
2010 StandoutNobel
Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction
2001 Standout
Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma.
1989 StandoutNobel
A Prospective Randomized Trial of Regional Versus Systemic Continuous 5-Fluorodeoxyuridine Chemotherapy in the Treatment of Colorectal Liver Metastases
1987
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
Carcinocythemia as the single extension of breast cancer: Report of a case and review of the literature
2001
Regimen-related toxicity in patients undergoing bone marrow transplantation.
1988 StandoutNobel
A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic Cancer
2004 Standout
Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience
2017
Imaging in the era of molecular oncology
2008 StandoutNature
Cushing's syndrome
2015 Standout
Head and neck cancer
2008 Standout
An Early Phase II Study of Oral S-1, a Newly Developed 5-Fluorouracil Derivative for Advanced and Recurrent Gastrointestinal Cancers
1999
Distinct Populations of Cancer Stem Cells Determine Tumor Growth and Metastatic Activity in Human Pancreatic Cancer
2007 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
2005 Standout
Patient noncompliance with self-administered chemotherapy
1990
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Intraarterial cisplatin and concurrent radiation for locally advanced bladder cancer.
1989
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
2004 Standout
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
A Comparison of Multimodal Therapy and Surgery for Esophageal Adenocarcinoma
1996 Standout
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Efficacy and tolerability of concurrent weekly low dose cisplatin during radiation treatment of localised muscle invasive bladder transitional cell carcinoma: A report of two sequential Phase II studies from the Trans Tasman Radiation Oncology Group
2006
A preliminary report: Concurrent twice-daily radiotherapy plus platinum-etoposide chemotherapy for limited small cell lung cancer
1988
Mechanisms involved in the side effects of glucocorticoids
2002 Standout
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
2020 Standout
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination
2000 Standout
Six Hundred Fifty Consecutive Pancreaticoduodenectomies in the 1990s
1997 Standout
Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
2007 Standout
Bladder cancer
2016 Standout
Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.
1993 Standout
Circulating mutant DNA to assess tumor dynamics
2008 Standout
EMT: 2016
2016 Standout
Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction
1992 Standout
Treatment compliance in childhood and adolescence
1993
Adenocarcinoma of the esophagus and esophguo-gastric junction: The effects of single and combined modalities on the survival and patterns of failure following treatment
1990
Adjuvant therapy in pancreatic cancer: historical and current perspectives
2003
Glucocorticoid Medication, Memory and Steroid Psychosis in Medical Illness
1997
Treatment of advanced and recurrent squamous carcinoma of the uterine cervix with constant intraarterial infusion of cisplatin
1988
Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer
1999 Standout
Pancreatic Carcinoma
1992
Challenges in the treatment of bladder cancer
2006
Circulating Cancer Cells in Peripheral Blood
2000
Radiotherapy for testicular seminoma stage I: Treatment results and long-term post-irradiation morbidity in 365 patients
1989
Phase II Study of S-1, a Novel Oral Derivative of 5-Fluorouracil, in Advanced Gastric Cancer
2000
S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
2008 Standout
Chemotherapy of gastric cancer
1988
Adherence to Medication
2005 Standout
Path model of multidimensional compliance with cancer therapy.
1987
Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer
2005
Compliance with oral drug therapy in patients with hematologic malignancy.
1987
Carcinocythemia (carcinoma cell leukemia). Report of two cases with english literature review
1984
5-Fluorouracil Incorporated into DNA Is Excised by the Smug1 DNA Glycosylase to Reduce Drug Cytotoxicity
2007 StandoutNobel
Depression Following Myocardial Infarction
1993 Standout
Distribution of papovavirus, myelin‐associated glycoprotein, and myelin basic protein in progressive multifocal leukoencephalopathy lesions
1982
Chemotherapy for advanced gastric cancer
2017 Standout
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Adenocarcinoma of the stomach: Areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy
1982
Systemic lupus erythematosus and myelofibrosis
1986 StandoutNobel
Review of the use of marrow transplantation in the treatment of non-Hodgkin's lymphoma.
1983 StandoutNobel
Carcinocythemia (carcinoma cell leukemia) due to metastatic carcinoma of the breast. Report of a case
1977
HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease.
1994 StandoutNobel
Myeloproliferative disorders (MPD): myelofibrosis, myelosclerosis, extramedullary hematopoiesis, undifferentiated MPD, and hemorrhagic thrombocythemia.
1975
The role of radiation therapy in the control of pain from pancreatic carcinoma
1988
The effects of intra-arterial bleomycin therapy on squamous cell carcinoma of the oral cavity
1975
Social Support and Patient Adherence to Medical Treatment: A Meta-Analysis.
2004 Standout
Four Decades of Continuing Innovation With Fluorouracil: Current and Future Approaches to Fluorouracil Chemoradiation Therapy
2004
Cisplatin
1984 Standout
Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine in Patients With Metastatic Melanoma
1999
Works of Sheldon Kaufman being referenced
Management of Lithium in Patients With Cancer
1993
Invasive bladder carcinoma: Preliminary report of selective bladder conservation by transurethral surgery, upfront MCV (Methotrexate, Cisplatin, and Vinblastine) chemotherapy and pelvic irradiation plus cisplatin
1988
Low dose fractionated whole body irradiation in the treatment of advanced non-Hodgkin's lymphoma
1979
Vinblastine, infusion, bleomycin, and cis-dichlorodiammine-platinum chemotherapy in metastatic melanoma
1981
Intraoperative radiation therapy in patients with bladder cancer. A review of techniques allowing improved tumor doses and providing high cure rates without loss of bladder function
1987
Case Report Simultaneous fungal and viral infection of the central nervous system
1978
5-drug adjuvant chemotherapy for breast cancer
1979
Case 6-1974
1974
Intraoperative Electron Beam Irradiation for Patients with Unresectable Pancreatic Carcinoma
1984
Regional hepatic chemotherapy using an implantable drug infusion pump
1983
Small cell carcinoma of the lung. A progress report of 15 years' experience
1987
Carcinocythemia (carcinoma cell leukemia)
1976
Combined modality treatment of gastric cancer
1983
Invasive bladder carcinoma. The importance of initial transurethral surgery and other significant prognostic factors for improved survival with full-dose irradiation
1987
Case 39-1974
1974
5-Fluorouracil in the Treatment of Gastrointestinal Neoplasia
1973